← back to search

Li Shen

Shanghai University of Traditional Chinese Medicine · CN
Area of research
Pharmacology · Cancer Research
Research interest
Research interests include MicroRNA in disease regulation, Healthcare and Venom Research, Bioinformatics and Genomic Networks, and Microbial Natural Products and Biosynthesis.
h-index
18
citations
1,853
works
69
NIH funding
primary concept
email

Recent publications

A Qualitative Study of Migraine Headache Experience in Patients with Patent Foramen Ovale Based on the Symptom Management Theory
Patient Preference and Adherence 2025cited by 1position: middledoi
rTFPI Protects Cardiomyocytes from Hypoxia/Reoxygenation Injury through Inhibiting Autophagy and the Class III PI3K/Beclin-1 Pathway
Cell Biochemistry and Biophysics 2022cited by 3position: middledoi
Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis
Frontiers in Oncology 2020cited by 19position: lastdoi
TFPIα alleviated vascular endothelial cell injury by inhibiting autophagy and the class III PI3K/Beclin-1 pathway
Thrombosis Research 2020cited by 6position: middledoi
MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway
Clinics and Research in Hepatology and Gastroenterology 2019cited by 61position: middledoi
AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation
Nature Chemical Biology 2012cited by 302position: middledoi

Grants

Collaborative Research: SCH: Personal Determinants of Health Enhanced Machine Learning Models for Early Prediction of Alzheimer's Disease and Related Dementias
NSF2500343$324,1602025–2029PIRePORTER
BIGDATA: IA: Collaborative Research: Asynchronous Distributed Machine Learning Framework for Multi-Site Collaborative Brain Big Data Mining
NSF1837964$316,0002019–2023PIRePORTER
SCH: INT: Mining Drug-Drug Interaction Induced Adverse Effects from Health Record Databases
NSF1827472$914,3542018–2022PIRePORTER
SCH: INT: Mining Drug-Drug Interaction Induced Adverse Effects from Health Record Databases
NSF1622526$1,165,7962016–2018PIRePORTER
III: Small: Collaborative Research: A Large-Scale Data Mining Framework for Genome-Wide Mapping of Multi-Modal Phenotypic Biomarkers and Outcome Prediction
NSF1117335$216,0002011–2015PIRePORTER

Frequent collaborators

Yong Zhao · Harbin Medical University2 papers (2020–2022)Yu Fu · Harbin Medical University2 papers (2020–2022)Runan Yan · Harbin Medical University2 papers (2020–2022)Wenjia Chen · National University of Singapore2 papers (2020–2022)Rui Xu · Nanjing University of Chinese Medicine2 papers (2020–2022)Qing Chang · Indiana University School of Medicine2 papers (2020–2022)Yue Liu · Nanchang University2 papers (2020–2022)Ning Zhang · Heilongjiang University of Chinese Medicine1 papers (2025–2025)Huawei Li · Allen Institute for Brain Science1 papers (2025–2025)Ruipeng Song · Ministry of Education of the People's Republic of China1 papers (2025–2025)Min Feng · Dalian Medical University1 papers (2025–2025)Yanyan Tao · Ministry of Education of the People's Republic of China1 papers (2019–2019)Junfan Wei · Guangzhou University of Chinese Medicine1 papers (2025–2025)Jiashu Li · Harbin Medical University1 papers (2020–2020)Mengtian Li · Shandong University of Traditional Chinese Medicine1 papers (2025–2025)Lei Yang · Fudan University1 papers (2019–2019)Qinglan Wang · Huazhong University of Science and Technology1 papers (2019–2019)Shiqiang Su · Chinese PLA General Hospital1 papers (2020–2020)Rahul M. Kohli · California University of Pennsylvania1 papers (2012–2012)Chenghai Liu · Ministry of Education of the People's Republic of China1 papers (2019–2019)